Niva Bupa Health Insurance Company Limited has informed the Exchange regarding 'Grant of Employee Stock Options to Eligible employees'.
NIVABUPA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Niva Bupa's board, at its May 7, 2025 meeting, approved the grant of 63,12,187 Employee Stock Options (ESOPs) to eligible employees under the ESOP Scheme 2024, priced at the weighted average market price. The board also appointed Mr. Vishwanath Mahendra (current CFO) and Mr. Ankur Kharbanda (current Chief Distribution Officer) as Whole-time Directors for 5-year terms, subject to shareholder and IRDAI approval. Ms. Joanne Elizabeth Woods resigned as Chief Risk Officer, with Mr. Vipul Sharma replacing her from May 8, 2025. Additionally, Nangia & Co. LLP was appointed as Statutory Auditor for 4 years and Ranjeet Pandey & Associates as Secretarial Auditor for 5 years.
The ESOP grant of ~63 lakh shares represents a small dilution, but aligns employee incentives with shareholders. The leadership changes and auditor appointments are largely routine corporate governance updates with no immediate material impact on stock price or business operations.